Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581K Sell
2,106
-339
-14% -$95.8K 0.01% 296
2026
Q1
$652K Buy
2,445
+25
+1% +$6.92K 0.01% 278
2025
Q4
$666K Hold
2,420
0.01% 268
2025
Q3
$698K Sell
2,420
-129
-5% -$38.2K 0.01% 264
2025
Q2
$843K Hold
2,549
0.02% 241
2025
Q1
$839K Sell
2,549
-17
-0.7% -$5.12K 0.02% 240
2024
Q4
$709K Buy
2,566
+23
+0.9% +$7.33K 0.01% 263
2024
Q3
$881K Hold
2,543
0.02% 250
2024
Q2
$841K Hold
2,543
0.02% 233
2024
Q1
$924K Buy
+2,543
New +$837K 0.02% 234

Other funds holding CI

Cannell & Spears's CI Position: Q2 2026 in Review

Cannell & Spears reduced its Cigna (CI) stake by 14% in Q2 2026, selling an estimated $95.8K and leaving 2,106 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #296.

Cannell & Spears first reported a position in CI in Q1 2024 and has held it in 10 quarters since. The position peaked at $924K in Q1 2024. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Cannell & Spears held 2,106 shares of Cigna worth $581K as of Q2 2026.
  • Cannell & Spears sold 339 Cigna shares in Q2 2026, an estimated $95.8K.
  • Cigna made up 0.01% of Cannell & Spears's portfolio in Q2 2026, its #296 holding.
  • Cannell & Spears first reported a position in Cigna in Q1 2024 and has held it in 10 quarters since.
  • Cannell & Spears's Cigna position peaked at $924K in Q1 2024.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.